Regenxbio (RGNX) Other Accumulated Expenses (2014 - 2025)

Regenxbio's Other Accumulated Expenses history runs 12 years deep, the most recent figure standing at $757000.0 for Q4 2025.

• In Q4 2025, Other Accumulated Expenses rose 16.64% year-over-year to $757000.0; the TTM figure through Dec 2025 stood at $757000.0 (up 16.64% YoY), while the FY2025 annual figure was $757000.0, up 16.64% from the prior year.
• Other Accumulated Expenses was $757000.0 for Q4 2025 at Regenxbio, down from $929000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $999000.0 in Q1 2023 to a low of $122000.0 in Q1 2021.
• Historically, Other Accumulated Expenses has averaged $697500.0 across 5 years, with a median of $748000.0 in 2022.
• Biggest YoY gain for Other Accumulated Expenses was 363.44% in 2021; the steepest drop was 58.64% in 2021.
• A 5-year view of Other Accumulated Expenses shows it stood at $744000.0 in 2021, then gained by 0.27% to $746000.0 in 2022, then plunged by 38.61% to $458000.0 in 2023, then soared by 41.7% to $649000.0 in 2024, then grew by 16.64% to $757000.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $757000.0 (Q4 2025), $929000.0 (Q3 2025), and $736000.0 (Q2 2025), per Business Quant data.